Key result
Multiplex ligation-dependent probe amplification (MLPA) confirmed all previously recognized mutations and increased the overall mutation pick-up rate by 33%.
Why the study?
Does the MLPA method improve mutation detection in the DMD gene compared to traditional methods in patients suspected of DMD or BMD?
Observational (n=196)
No
Does the MLPA method improve mutation detection in the DMD gene compared to traditional methods in patients suspected of DMD or BMD?
Answers are grounded in this paper and cite their sources.
The MLPA method is a highly reproducible and effective diagnostic tool that significantly increases the mutation detection rate for Duchenne and Becker muscular dystrophies.
Mutation detection in the DMD gene defective in Duchenne (DMD) and Becker muscular dystrophies (BMD) is complicated by the presence of 79 exons. The majority of recognized mutations are, however, copy number changes of individual exons, which traditionally have been identified by three common multiplex polymerase chain reaction (PCR) assays and/or Southern blotting. Here we report the use of the newly developed quantitative assay multiplex ligation-dependent probe amplification (MLPA) to determine the copy number of each of the 79 DMD exons in 182 males and 14 carrier females referred to our diagnostic facility on the clinical suspicion of DMD or BMD. The MLPA method confirmed all previously recognized mutations and identified an additional 28, including four point mutations. Also, the assay reliably identified 7 carrier females, which are usually not easily recognized. In our hands the method is highly reproducible, easy to handle, and has increased our mutation pick-up rate by a total of 33%.
No takes yet. Share an insight, caveat, or question.
Schwartz et al. (2004) conducted an observational in Duchenne and Becker muscular dystrophies (n=196). Multiplex ligation-dependent probe amplification (MLPA) vs. Multiplex PCR and/or Southern blotting was evaluated on Mutation detection rate. Multiplex ligation-dependent probe amplification (MLPA) confirmed all previously recognized mutations and increased the overall mutation pick-up rate by 33%.
Synapse has enriched 10 related papers. Consider them for comparative context: